Abstract:Aims/Purpose: The detrimental effects of tear hyperosmolarity on human corneal epithelial (HCE) cells is a primary cause of dry eye syndrome (DES). However, the molecular mechanisms underlying inflammatory processes and cellular dysfunction in HCE are largely unknown. This study characterized the proteome changes in an optimized hyperosmolarity‐induced DES model in vitro. Methods: An in vitro hyperosmolar (400–550 mOsm) DES model was established in a simian virus 40 (SV40)‐immortalized HCE cell line. Cells incubated in medium with physiological osmolarity (312 mOsm) were used as control. Cell viability, cell death and intracellular reactive oxygen species (ROS) levels were analysed with MTS, Annexin‐V‐FLUOS, crystal violet and DCFDA assays. Mass spectrometry‐based proteomics analyses characterized the proteome and elucidated the underlying molecular changes. Results: The HCE cell viability was significantly decreased in a concentration‐dependent manner with increasing hyperosmolarity compared to control at 48 hr (450 mOsm, −47%, p = 2.7 × 10 −8 ; 500 mOsm, −71%, p = 1.1 × 10 −4 ; 550 mOsm, −84%, p = 2.6 × 10 −5 ). Notably, cell adherence was significantly decreased ( p = 5.8 × 10 −9 ), while levels of ROS ( p = 3.6 × 10 −2 ) and apoptosis ( p = 3.6 × 10 −2 ) were significantly increased at 450 mOsm compared to control. Proteomics analysis identified ~2000 proteins (FDR <1%) and, as many as 215 proteins were found to be significantly ( p < 0.05) differentially abundant in the 450 vs. 312 mOsm. The effects of high hyperosmolarity (450 mOsm)‐induced damage resembling DES on the HCE cell were further demonstrated by the expression of proteins involved in the activation of inflammatory response ( p = 5.5 × 10 −3 ), apoptosis ( p = 5.3 × 10 −4 ) and generation of ROS (e.g., glutathione S‐transferase P) ( p = 7.1 × 10 −3 ). Moreover, many differentially expressed proteins were also implicated in the regulation of cell viability ( p = 1.1 × 10 −6 ) and organization of cytoplasm (e.g., cyclase associated actin cytoskeleton regulatory protein 1) ( p = 2.4 × 10 −2 ). Conclusions: In summary, an optimized hyperosmolarity‐induced DES cell culture model for proteomics analysis was established, and specific alterations in the proteome were characterized in this model. This in vitro model would be instrumental for testing therapeutic targets for DES in the future.

Integrated tear proteome and metabolome reveal panels of inflammatory-related molecules via key regulatory pathways in dry eye syndrome.

The Alterations of Ocular Surface Metabolism and the Related Immunity Inflammation in Dry Eye

Novel pathomechanisms of impairment of native tear protein complexes in aqueous deficient dry eye syndrome

The Use of In-Strip Digestion for Fast Proteomic Analysis on Tear Fluid from Dry Eye Patients

The role of exocytotic proteins in the (dys)regulation of human reflex tearing and aqueous‐deficient dry eye syndrome

Analysis Of Th17-Associated Cytokines And Clinical Correlations In Patients With Dry Eye Disease

Expressions and Significances of Tumor Necrosis Factor-α and Interleukin-1β in the Conjunctival Epithelial Cells and Tear of Patients with Dry Eye Syndrome

The Correlation of Cytokines and Sensory Hypersensitivity in Mild Dry Eye Patients Characterized by Symptoms Outweighing Signs.

Single-cell landscape reveals the epithelial cell-centric pro-inflammatory immune microenvironment in dry eye development

Identification of Tear Fluid Biomarkers in Dry Eye Syndrome Using Itraq Quantitative Proteomics.

A Mechanism Study of Electroacupuncture for Dry Eye Syndrome by Targeting Conjunctival Cytokine Expressions

Global Metabonomic and Proteomic Analysis of Human Conjunctival Epithelial Cells (IOBA-NHC) in Response to Hyperosmotic Stress

Characterization of the proteome changes in an in vitro hyperosmotic dry eye model employing human corneal epithelial cells

Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease

Dry eye syndrome: comprehensive etiologies and recent clinical trials

Nanomedicines for Dry Eye Syndrome: Targeting Oxidative Stress with Modern Nanomaterial Strategies

Effectiveness of acupuncture combined with artificial tears in managing dry eye syndrome: A systematic review and meta-analysis

Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease

Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine

Tear Proteomic Analysis of Sjögren Syndrome Patients with Dry Eye Syndrome by Two-Dimensional-nano-liquid Chromatography Coupled with Tandem Mass Spectrometry

Development of Lutein-Containing Eye Drops for the Treatment of Dry Eye Syndrome